| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |